Valuation check: TBGNF's profit margin is -7086.47%, below the Healthcare sector average of 10.58%.
Get informed when a big investor buys or sells
+ FollowAs of Dec 2024
Trailing 12 months ending Dec 2024
Oxurion N.V. (TBGNF) currently reports a profit margin of -7086.47% as of December 2024. That compares with -3531.22% in the prior-year period — down 100.7% year over year. That is below the Healthcare sector average of 10.58%. Use the charts on this page to explore Oxurion N.V.'s profit margin history and peer comparisons.
Oxurion N.V.'s profit margin decreased from -3531.22% to -7086.47% — a 100.7% year-over-year decrease (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Oxurion N.V.'s profit margin of -7086.47% is lower than the Healthcare sector average of 10.58%. That is roughly 67076.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Oxurion N.V.'s current -7086.47% should be judged against Healthcare norms (sector average: 10.58%) and against TBGNF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -7086.47%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 10.58%. From there, open related valuation or income-statement pages for Oxurion N.V., and consider following TBGNF for alerts when major investors trade the stock.